Interleukin‐6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID‐TIMI 52 (Stabilization of Plaque Using Darapladib—Thrombolysis in Myocardial Infarction 52) Trial

BACKGROUND: Interleukin‐6 (IL‐6) is an inflammatory cytokine implicated in plaque instability in acute coronary syndrome (ACS). We aimed to evaluate the prognostic implications of IL‐6 post‐ACS. METHODS AND RESULTS: IL‐6 concentration was assessed at baseline in 4939 subjects in SOLID‐TIMI 52 (Stabi...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Am Heart Assoc
मुख्य लेखकों: Fanola, Christina L., Morrow, David A., Cannon, Christopher P., Jarolim, Petr, Lukas, Mary Ann, Bode, Christoph, Hochman, Judith S., Goodrich, Erica L., Braunwald, Eugene, O'Donoghue, Michelle L.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: John Wiley and Sons Inc. 2017
विषय:
Original Research
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5721825/
https://ncbi.nlm.nih.gov/pubmed/29066436
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.005637
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन